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Werner syndrome (WS) is the hallmark premature aging
disorder in which affected humans appear older than
their chronological age. The protein WRNp, defective in
WS, has helicase function, DNA-dependent ATPase, and
exonuclease activity. Although WRNp functions in
nucleic acid metabolism, there is little or no information
about the pathways or protein interactions in which it
participates. Here we identify Ku70 and Ku86 as proteins
that interact with WRNp. Although Ku proteins had no
effect on ATPase or helicase activity, they strongly
stimulated specific exonuclease activity. These results
suggest that WRNp and the Ku complex participate in a
common DNA metabolic pathway.
Received January 21, 2000; revised version accepted March 7,
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Werner syndrome (WS) is a human premature aging dis-
order characterized by the early display of many of the
signs and symptoms that are associated with the normal
aging process. Cells from WS patients also show a num-
ber of phenotypic changes typical of chronologically
older normal cells including increased chromosomal ab-
normalities and rapid onset of cellular senescence (Mar-
tin 1997). WS cells are not generally sensitive to DNA-
damaging agents but are hypersensitive to the carcinogen
4 nitroquinoline (4NQO) and topoisomerase I-specific
inhibitor, campthothecin (Lebel and Leder 1998). The
WS gene WRN (Yu et al. 1996) is a member of the RecQ
family that includes the RecQ4 and BLM genes, defects
that are responsible for the premature aging and cancer
prone phenotypes of Rothmund-Thomson (Kitao et al.
1999) and Bloom syndrome (Ellis 1997), respectively.
These syndromes are characterized by a high degree
of genomic instability, including chromosomal breaks,
multiple large deletions, and translocations (Moser et al.
1999). WRNp has helicase activity and an associated
DNA-dependent ATPase activity (Gray et al. 1997; Brosh
et al. 1999). WRNp also has an exonuclease function lo-
cated in its amino-terminal region. Two laboratories
have identified the directionality of the exonuclease to
be 38 → 58 (Huang et al. 1998; Kamath-Loeb et al. 1998;
Shen et al. 1998), whereas one laboratory reported a
58 → 38 directionality (Suzuki et al. 1999).
The enzymatic functions of WRNp indicate a role in
nucleic acid metabolism, but information about the
pathways in which it participates is lacking. In this
study we used a chromatographic procedure to isolate
proteins that bind to WRNp. This approach identified
Ku70 and Ku86. This physical interaction between the
Ku86/70 complex was verified by immunoprecipitation
from cell extracts. Moreover, the Ku86/70 complex func-
tionally interacts with WRNp, strongly stimulating the
38 → 58 exonuclease activity of WRNp.
Results
The carboxyl terminus of WRNp interacts physically
with the Ku86/70 complex
The exonuclease domain of WRNp is located in the
amino-terminal end of the protein and the helicase/
ATPase domain in its central part (Fig. 1A). Because the
carboxyl terminus (C-WRNp) of WRNp lacks homology
to known functional domains, we searched for interac-
tions with this portion of the protein. The carboxyl ter-
minus was cloned into an Escherichia coli expression
vector and the recombinant protein was expressed and
purified (Fig. 1B). This fragment was immobilized on an
agarose bead matrix, and specific proteins were identi-
fied by chromatographing HeLa nuclear extract through
the column. Columns either without protein attached or
with excess b-galactosidase were used to identify pro-
teins that bound nonspecifically. Proteins were eluted
with increasing salt concentrations. Radioactively la-
beled extract was used to identify a 160-kD band on SDS-
PAGE, which was shown to be full-length WRNp by
Western blot (Fig. 2). This result suggests dimerization or
a higher order assembly of WRNp, an observation that
has not been reported previously.
Two strong bands (Fig. 3A, arrows) were observed in
the 0.2-M salt eluate at ∼70 and 90 kD, which were not
present in the eluate from the b-galactosidase or matrix
columns. These bands were excised and identified by
matrix-assisted laser desorption ionization mass spec-
trometry (MALDI–MS) to be the Ku70 and Ku86 pro-
teins. The identities of the Ku proteins were verified by
Western blot (Fig. 3B) using antibodies against Ku70 and
Ku86. As there was no binding of Ku70 or Ku86 to either
the b-galactosidase or matrix alone column (Fig. 3B), the
C-WRN interactions with Ku proteins appears to be spe-
cific. Fluorimager analysis demonstrated that the recom-
binant C-WRNp and Ku proteins contained no DNA,
ruling out that the interactions were mediated via DNA
(data not shown).
To confirm this interaction in vivo and to investigate
whether the Ku proteins bind to full-length WRNp, an
antibody against the amino terminus of WRNp was gen-
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erated and used to immunoprecipitate full-length WRNp
and associated proteins from cell extracts. The antibody
immunoprecipitated WRNp (Fig. 4B, lane 1) and coim-
munoprecipitated Ku86 and Ku70 (Fig. 4A, lane 1). Im-
munoprecipitation of the HeLa cell extracts with anti-
bodies to Ku70, Ku86, and Ku86/70 showed interaction
by Western blot with Ku86 and Ku70 as expected (Fig.
4A) and with full-length WRNp (Fig 4B). The nuclear
extract served as a control to locate the Ku bands. This
interaction was also verified by immunoprecipitation of
purified proteins (M. Cooper, unpubl.). Furthermore,
WRNp was not immunoprecipitated from a WS fibro-
blast cell extract with a Ku antibody (data not shown).
Ku complex has no effect on WRNp helicase
or ATPase activities
Next, we investigated whether the physical interaction
between WRNp and the Ku86/70 complex might medi-
ate a change in WRNp activity. WRNp is a processive
DNA-dependent ATPase that prefers ssDNA as the
DNA effector (Orren et al. 1999; Brosh et al. 1999). The
ATPase activity (kcat) of WRNp (7 nM) in the absence of
Ku86/70 was determined to be 139/min, consistent with
previously published data (Orren et al. 1999; Brosh et al.
1999). In control reactions, Ku86/70 (70 nM, heterotri-
mer) alone did not demonstrate any detectable ATP hy-
drolysis over background. When Ku86/70 and WRNp
were preincubated together with M13 ssDNA and reac-
tions were initiated with [3H]ATP, the kcat for ATP hy-
drolysis by WRNp was 152/min, indicating that Ku pro-
tein does not significantly modulate ATP hydrolysis
catalyzed by WRNp.
The helicase activity of WRNp was examined on a
M13 28-bp partial duplex DNA substrate in the presence
or absence of Ku86/70 (Fig. 5A). Reaction products were
analyzed by nondenaturing gel electrophoresis. WRNp
(15 nM monomer) alone unwound ∼70% of the helicase
substrate in a 30-min reaction (Fig. 5A, lane 1), whereas
Ku86/70 (128 nM) alone did not detectably unwind the
double-stranded (ds) DNA substrate (Fig. 5A, lane 7).
When WRNp and Ku86/70 were preincubated together
with the dsDNA substrate and reactions were initiated
with ATP, Ku86/70 (8–128 nM) had no effect on WRNp
helicase activity (Fig. 5A, lanes 2–6). Moreover, Ku86/70
(8–128 nM) did not stimulate WRNp helicase activity on
the 28-bp partial duplex substrate with an amount of
WRNp (3 nM monomer) that unwinds only 5% of the
duplex DNA substrate (A. Machwe
and D. Orren, unpubl.). These results
demonstrate that Ku86/70 neither
stimulates nor inhibits WRN helicase
activity on short DNA duplexes.
Ku70/86 stimulates WRN
exonuclease activity
WRNp has been reported previously
to be an exonuclease with either
38 → 58 or 58 → 38 directionality. Our
studies agree with the notion that
WRNp is a 38 → 58 exonuclease with preference for 38
recessed ends (Fig. 5; D. Orren, unpubl.). To examine the
effect of Ku86/70 on the exonuclease activity of WRNp,
a DNA substrate with one blunt end and one recessed 38
end was designed (Fig. 5B) that is not detectably un-
wound by the helicase activity of WRNp (data not
shown). Exonuclease digestion of this substrate by
WRNp in the presence or absence of Ku86/70 is shown
in Figure 5C. Ku86/70 alone does not have nuclease ac-
tivity on this substrate. At low concentrations of WRNp
alone, digestion from the 38 recessed end is limited. At
higher concentrations of WRNp, there is extensive
38 → 58 exonuclease activity (Fig. 5C, lane 8, 120 fmoles).
When Ku86/70 is added with WRNp, the extent of di-
gestion into the substrate is increased dramatically (Fig.
5C,D). Heat inactivation of Ku86/70 completely abol-
ishes this stimulatory effect (Fig. 5C). Moreover, a
WRNp with a mutation at a conserved amino acid
(E84A) in its nuclease domain (Huang et al. 1998) has no
detectable 38 → 58 exonuclease activity whether Ku86/
70 is present or not (Fig. 5C). These results show that
addition of Ku86/70 stimulates the 38–58 exonuclease
activity of WRNp. The stimulation of wild-type WRNp
exonuclease activity occurs over a broad range of Ku86/
70 concentrations, and appears to be optimal at approxi-
mately equimolar ratios (Fig. 5E). In contrast, the addi-
tion of Ku86/70 does not detectably stimulate the
38 → 58 exonuclease activities of other exonucleases,
prokaryotic exonuclease III or the Klenow fragment of
DNA polymerase I (Fig. 5F). Thus, this stimulation of
exonuclease activity is specific for WRNp.
The Ku complex has been reported to have some DNA
unwinding activity (Tuteja et al. 1994; Yoo and Dynan
1998), although other studies find no unwinding (Tuteja
Figure 1. Purification of the carboxyl terminus of Werner protein. (A) Schematic of
C-WRNp fragment. The amino terminus contains the 3 conserved exonuclease motifs.
The central region contains the conserved 7 motif helicase domain. (B) SDS-PAGE with
Coomassie staining of C-WRNp.
Figure 2. Specific proteins bound to C-WRNp. C-WRNp binds
to full-length WRNp (∼160 kD). Western blot with anti-WRNp
antibody. (Lane 1) Nuclear extract, positive control; (lane 2)
b-galactosidase column eluate; (lane 3) C-WRNp column eluate.
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et al. 1994). We did not observe any unwinding of a M13
partial duplex substrate by Ku86/70 (Fig. 5A) or of the
dsDNA substrate (Fig. 5B) used for exonuclease studies
(data not shown). A possible source of this controversy
might arise from its tight binding to WRNp, which could
result in copurification of WRNp in Ku preparations.
The possibility existed that Ku86/70, in the
presence of ATP, caused a local unwinding of the
substrate that would then stimulate the exonucle-
ase activity of WRNp. To test this possibility, we
performed an exonuclease assay in the absence of
ATP (Fig. 5F). Ku86/70 still greatly stimulates the
WRN exonuclease activity under those condi-
tions. This stimulation is also observed in a
WRNp K mutant, devoid of helicase activity
(Brosh et al. 1999) (Fig. 5G, lanes 5,6). These re-
sults rule out the possibility that either WRNp or
Ku unwinding activity is involved in the stimula-
tion of WRN exonuclease.
Discussion
We have shown that the carboxyl terminus of the
WRNp interacts strongly with the Ku86/70 com-
plex. This physical interaction was also observed
in cell extracts and between the purified proteins.
We ascertained that no DNA was present under
these conditions, thus excluding the hypothesis
that this interaction could occur via a DNA
bridge. The Ku86/70 complex strongly stimulated
the exonuclease activity of WRNp, although it had
no effect on its DNA-dependent ATPase or heli-
case activity. This stimulatory effect is mediated
by the interaction between WRNp and Ku86/70 and
serves to dramatically enhance the processivity of the
exonuclease function of WRNp. The functional effect of
this interaction occurs at the amino terminus, where the
exonuclease activity is located. It is possible that there
are other binding sites between Ku86/70 and WRNp.
The interaction with Ku stimulates the exonuclease ac-
tivity of WRNp via a direct molecular binding without
any local unwinding of DNA by the Ku86/70 complex.
Several studies have shown that Ku86/70 binds to
DNA ends and other types of discontinuity in dsDNA
(Smith and Jackson 1999). It is a tightly associated het-
erodimer that, together with the ∼470-kD catalytic sub-
unit, DNA–PKcs, form the DNA-dependent protein ki-
nase (Featherstone and Jackson 1999). This complex is
involved in repairing DNA double-strand breaks (DSBs)
formed during V(D)J recombination or caused, for ex-
ample, by endogenous oxidative byproducts, ionizing ra-
diation, or certain chemotherapeutic drugs. A current
model proposes that the complex joins the DNA ends,
whereas a helicase unwinds the DNA duplex locally at
the break, permitting annealing of the broken strands at
sites of microhomology (Smith and Jackson 1999). The
unannealed DNA ends then might be trimmed by an
exonuclease before gap-filling and ligation by a polymer-
ase and ligase (Yoo and Dynan 1998). No specific heli-
case or exonuclease that is involved in this process in
mammalian cells has as yet been identified. Such exo-
nuclease activity could be performed by WRNp, and the
WRNp helicase activity may also participate in the pro-
cess. WRNp and Ku could act together in recombination
and/or DSB repair pathways. Our results suggest that Ku
might help direct and stimulate WRN exonuclease ac-
tivity on DNA ends.
Figure 4. WRNp and Ku complex coimmunoprecipitate. (A) Polyclonal
antibody raised against the amino terminus of WRN (amino acids 1–600,
designated N-WRN) was raised in mouse. The blot was sequentially
probed with the Ku86 and Ku70 antibodies. (Lane 1) Anti-WRN mouse
polyclonal antibody immunoprecipitate; (lane 2) anti-Ku70 mouse mono-
clonal antibody immunoprecipitate; (lane 3) anti-Ku86 mouse monoclonal
antibody immunoprecipitate; (lane 4) anit-Ku70/86 goat polyclonal anti-
body immunoprecipitate; (lane 5) goat immunoglobin precipitate; (lane 6)
mouse immunoglobin precipitate; (lane 7) blank; (lane 8) HeLa nuclear
extract, unprecipitated, to mark the positions of Ku86 and Ku70. (B) Im-
munoprecipitation of WRNp by antibodies specific for N-WRN, Ku70,
Ku86, and the Ku86/70 heterodimer. The insert labeled WRN (lane 1)
shows the anti-N-WRN antibody immunoprecipitate probed with poly-
colonal antibodies against the carboxyl terminus of WRN (prepared simi-
larly to the anti-N WRN antibody), demonstrating that the anti-N-WRN
antibody is specific for full-length WRN. (Lane 2) Anti-Ku70 mouse mAb
immunoprecipitate; (lane 3) anti-Ku86 mouse mAb immunoprecipitate;
(lane 4) anti-Ku86/70 goat polyclonal antibody immunoprecipitate; (lane
5) mouse immunoglobulin immunoprecipitate; (lane 6) HeLa nuclear ex-
tract, unprecipitated, to mark the position of WRNp.
Figure 3. Ku proteins interact with C-WRNp. (A) Two proteins
tightly associated with C-WRNp were identified by Coomassie
staining of samples analyzed by SDS-PAGE. (Lane 1) Marker;
(lane 2) no protein column; (lane 3) b-galactosidase column;
(lane 4) C-WRNp column. (Arrows) Proteins that associated
with C-WRNp specifically. (B) Western analysis using antibod-
ies against Ku86 and Ku70 identify the two specific proteins as
the Ku proteins. Antibodies against Ku86 and Ku70 were ob-
tained from Oncogene Research Products (Cambridge, MA) and
used to sequentially probe the membrane.
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There is good evidence for a role of the WRNp in DNA
replication. A prolonged S phase has been observed in
WS cells (Poot et al. 1992). The WRNp is 66% homolo-
gous to the Xenopus laevis FFA1 protein (foci-forming
activity 1), which is essential for the formation of repli-
cation origins and RPA aggregation (Yan et al. 1998). We
have reported previously that WRNp interacts physically
and functionally with RPA (Brosh et al. 1999). Further-
more, the WRNp is a part of the replication complex
(Lebel et al. 1999). The Ku86/70 and DNA–PK complex
is also involved in DNA replication (Ruiz et al. 1999),
and thus the main interaction between the Ku complex
and WRNp may be via both of their roles in the replica-
tion process.
WS cells are not generally hypersensitive to DNA
damaging agents. They are, however, sensitive to the car-
cinogen 4NQO (Gebhart et al. 1988) and to certain to-
poisomerase inhibitors such as the topisomerase I inhibi-
tor, camptothecin (Lebel and Leder 1998). One study re-
ports a repair deficiency for higher dose X-ray-induced
damage (Weirich-Schwaiger et al. 1994), but others do
not. The genomic instability in WS cells (Martin 1997)
Figure 5. WRN exonuclease, but not helicase, is stimulated by Ku86/70. (A) WRNp (15 nM monomer) was incubated with the 28-bp
partial duplex in the presence of the indicated concentrations of Ku86/70 under standard helicase reactions (Brosh et al. 1999). Lanes
show increasing concentrations of Ku86/70. (Lane 7) No WRNp added, shows that Ku proteins do not unwind this substrate. ( )
Heat-denatured control. (B) The exonuclease substrate containing a 58 overhang. (C) Ku stimulation of WRN exonuclease at different
concentrations of WRN (fmoles); Ku was 64 fmoles (10 ng). (D) Heat denaturation of Ku86/70. (Exo-) Mutant WRNp with no
exonuclease activity. (D) Scans of lanes 5 and 6. (E) Ku86/70 stimulation of WRN exonuclease (at 45 fmoles), Ku titration. (F) Ku does
not stimulate Exonuclease III or Klenow. (G) Ku stimulates WRN [wild-type and helicase mutant (Brosh et al. 1999)] exonuclease (both
at 120 fmoles) in the absence of ATP.
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and the high frequency of deletions and translocations
could be compatible with a DSB repair defect. We are
currently investigating this in more detail, but as no cell
lines with functional domain knockout in the WRN gene
are yet available, many primary WS cell lines need to be
analyzed.
If WRNp and Ku86/70 act in the same pathway, defi-
ciencies in either component would be expected to have
similar biochemical and cellular phenotypes. This no-
tion is supported by a recent characterization of the
Ku86 knockout mouse. The mouse has a senescent phe-
notype and, like WS patients, shows early onset of many
age-related changes and a shortened life span (Vogel et al.
1999). Furthermore, cells deficient in WRNp, Ku70, or
Ku86 undergo premature replicative senescence (Gu et
al. 1997) and have elevated levels of chromosomal ab-
normalities. These similarities combined with our ex-
perimental results suggest that WRNp and Ku86/70
function in a common pathway, most likely in replica-
tion, recombination, or DSB repair. Our data might argue




The matrix-assisted laser desorption ionization mass spectrometry
(MALDI–MS) was performed by the HHMI/Keck facility at Yale Univer-
sity, where information is posted on the website: http://info.med.
yale.edu/wmkeck.
Preparation of WRNp antibodies
Purified denatured N-WRN (100 µg) was injected intraperitoneal on day
0, and booster injections were administered at day 21 and day 28. Serum
was collected from tail bleeds and used for immunoprecipitation.
Purification of WRNp and Ku complex
Recombinant human Ku was expressed in insect cells using baculoviral
constructs and 70- and 86-kD subunits were amplified by PCR from
cDNAs (a gift of D. Capra, University of Washington School of Medicine,
Seattle). The 70-kD subunit was modified such that the amino acid se-
quence LEIEGRHHHHHH was placed in front of the stop codon at the
carboxyl terminus. Both coding sequences were placed in pFASTBAC1,
their sequence verified correct as reported, and high titer viral stocks for
each subunit made by the BAC to BAC system (Life Technologies Incor-
porated, Bethesda, MD). SF-9 cells were coinfected with viruses for both
subunits. An extract from an infection of ∼0.5 liters of Sf9 cells (∼1 × 109
cells) was prepared and heterodimeric Ku purified by successive chroma-
tography of Ku-containing fractions over a Ni–NTA Superflow (Qiagen)
column, a Mono Q (Pharmacia) column, and a native DNA cellulose
(Sigma) column as described previously (Ramsden and Gellert 1998). The
peak fraction was dialyzed against a buffer containing 25 mM Tris-HCl
(pH 8.0), 150 mM KCl, 10% glycerol, 2 mM DTT, frozen in small aliquots
on liquid nitrogen, and stored at −80°C. The final fraction from such
preparations was determined to be a 1:1 heterodimer, >98% pure, as
determined by chromatography on an S200 column (Pharmacia) and Coo-
massie staining of protein run on a SDS–polyacrylamide gel. The activity
of the protein preparation was tested by gel-shift assay and stimulation of
mammalian ligase (data not shown).
The WRNp was purified as described (Orren et al. 1999). A series of
extra chromatographic steps were included to secure a high degree of
purity of the protein (Orren et al. 1999).
Purification of the carboxyl terminus of WRNp
The gene encoding human WRNp (kindly provided by Dr. Junko Oshima,
University of Washington Medical School, Seattle) was subjected to PCR
of the carboxyl terminus (the region encoding amino acids 940–1432 and
designated C-WRN). The product was subcloned into pET 30a (Novagen,
Madison, WI) and confirmed by restriction analysis and sequence as the
carboxyl terminus of WRN. The clone was then overexpressed in E. coli
(BL21-DE3) and grown as described previously (Cooper et al. 1999). Cul-
ture flasks containing induced cells were stored on ice for 10 min, and the
cells were pelleted. The pellet was frozen on liquid nitrogen and stored at
−80°C overnight. The pellet was resuspended in 300 ml of ice cold lysis
buffer (50 mM HEPES at pH 7.8, 0.2 M NaCl, 0.1% Triton X-100, 1 mg/ml
lysozyme, 5 mM b-mercaptoethanol, 1 mM PMSF, 10 µg/ml leupeptin, 10
µg/ml pepstatin A, and 10 mg/ml aprotinin). The sample was subjected
to two 10-sec cycles of sonication on ice. The lysate containing C-WRNp
was clarified at 20,000g for 1 hr at 4°C and filtered through a 0.22-µm
filter. The lysate was loaded onto a 35-ml SP Sepharose column (Phar-
macia). The column was washed with 10-column volumes of lysis buffer
and eluted on a 0.2–0.5 M NaCl gradient. The fractions containing C-
WRNp of ∼90% purity were pooled and loaded onto a 5-ml Ni2+–NTA
resin column (Qiagen). The sample was sequentially washed with 10-
column volumes of binding buffer (50 mM NaH2PO4, 0.3 M NaCl, 0.1%
Triton X-100, 10 mM imidazole, and 5 mM b-mercaptoethanol) and 10
column volumes of wash buffer (binding buffer with a final concentration
of 20 mM imidazole). The bound C-WRN protein was then eluted with a
20 mM–1 M imidazole gradient. Fractions containing purified C-WRN
protein were pooled and dialyzed against 50 mM HEPES (pH 7.5), 0.4 M
NaCl, 1 mM EDTA, and 2 mM DTT for 1 hr at 4°C. The purified C-WRN
was concentrated by membrane filtration (Amicon), frozen on liquid ni-
trogen, and stored at −80°C. The typical yield of protein from 1 liter of
culture was 14 mg.
Affinity chromatography to C-WRN
Purified C-WRNp (1.5 mg) was immobilized to an activated 4% beaded
agarose matrix by reductive amination of Schiff bases (Pierce, Rockford,
IL) as per the manufacturer’s instructions. Control columns containing a
fivefold excess of b-galactosidase (7.5 mg) or matrix only were prepared
similarly. The procedures described previously (Hughes and Baldacci
1997; Fahrmann et al. 1998) were modified. Columns were equilibrated
in 10 column volumes of binding buffer (50 mM HEPES at pH 7.4, 0.1 M
NaCl, 0.05% Triton X-100, 1 mM EDTA, 1 mM Na vanadate, 1 mM NaF,
1 mM DTT, 1 mM PMSF, 10 µg/ml leupeptin, 10 µ/ml pepstatin A, and
10 µg/ml aprotinin. Nuclear extract (20 mg) prepared from HeLa cells
was sequentially incubated for 1 hr at 4°C with the no protein column,
the b-galactosidase column, and the C-WRNp column, respectively. Pro-
teins adsorbed to the columns were washed with 10 column volumes of
binding buffer to remove weakly bound proteins. The columns were then
step eluted with binding buffer containing 0.2 M NaCl and 1 M NaCl to
identify tight binding proteins. The eluted fractions were dialyzed and
concentrated by membrane filtration (Amicon), lyophilized, and samples
were analyzed by SDS-PAGE (10%) followed by either Coomassie stain-
ing or Western blot. All columns were prepared fresh for each experiment
and all results were duplicated.
Immunoprecipitation assays
Immunoprecipation of WRNp was performed in IP buffer (50 mM HEPES
at pH 7.4, 0.1 M NaCl, 0.05% Triton X-100, 1 mM EDTA, 1 mM Na
vanadate, 1 mM NaF, 1 mM DTT, 1 mM PMSF, 10 µg/ml leupeptin, 10
µg/ml pepstatin A, and 10 µg/ml aprotinin). Briefly, HeLa nuclear extract
(500 µg) was precleared with either mouse or goat immunoglobin and
preswollen protein A/G beads for 1 hr at 4°C. The precleared extract was
incubated with the anti-N-WRN antibody for 1–2 hr at 4°C and preswol-
len protein A/G beads added. The complex was pelleted and washed four
times with IP buffer. The precipitates were subjected to SDS-PAGE (10%)
and Western blot analysis.
ATPase assay
ATPase assay reaction mixtures (20 µl) contained 40 mM Tris (pH 7.4), 4
mM MgCl2, 5 mM DTT, M13mp18 ssDNA (30 µM nucleotide phosphate),
0.8 mM [3H]ATP (42 cpm/pmole), WRN protein (7 nM, monomer) and/or
Ku protein (70 nM heterodimer). WRN and Ku proteins were preincubated
for 2 min at 24°C in ATPase reaction buffer containing M13 ssDNA
effector. Reactions were initiated by the addition of [3H]ATP and incu-
bated at 24°C for 10 min. Samples (5 µl) were removed and evaluated by
TLC as described previously (Matson and Richardson 1983). Less than
20% of the substrate ATP was consumed in the reaction over the entire
time course of the experiment.
Helicase assay
Helicase assay reaction mixtures (20 µl) contained 40 mM Tris (pH 7.4), 4
mM MgCl2, 5 mM DTT, 2 mM ATP, WRN helicase (15 nM, monomer),
and the indicated amount of Ku86/70 protein. The concentration of the
Ku complex stimulates the Werner protein
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28-bp partial duplex helicase substrate in the reaction mixture was ∼2 µM
(nucleotide phosphate). WRN and Ku proteins were preincubated with
partial duplex DNA substrate for 2 min at 24°C before reactions were
initiated by the addition of ATP and incubated at 24°C for 30 min. Re-
actions were terminated by the addition of 10 µl of 50 mM EDTA, 40%
glycerol, 0.9% SDS, 0.1% bromophenol blue, and 0.1% xylene cyanol.
The products of helicase were resolved on a 12% nondenaturing poly-
acrylamide gel. Radiolabeled DNA species in polyacrylamide gels
were visualized by a PhosphorImager or film autoradiography and quan-
titated using ImageQuant software (Molecular Dynamics). The percent
helicase substrate unwound was calculated by the following formula: %
Displacement = 100 × P/(S + P). P is the product volume and S is the
substrate volume. The values for P and S have been corrected after sub-
tracting background values in the no enzyme and heat-denatured con-
trols, respectively.
Exonuclease assay
Single-stranded, partially complementary DNA oligonucleotides (32 and
43 nucleotides) were obtained from GIBCO BRL, and the 32 nucleotide (7
pmoles) was 58 labeled with [g-32P]ATP (60 µCi, 3000 Ci/mmole) and
polynucleotide kinase (10 units) using standard conditions. For construc-
tion of a dsDNA substrate with one blunt end and one 38-recessed (58
overhang) end (Fig. 5B), labeled 32-mers were mixed with a twofold ex-
cess of unlabeled 43-mer, heated together at 90°C for 5 min, then cooled
slowly to 25°C. The annealed dsDNA was then separated from unan-
nealed and excess single-stranded oligonucleotides by nondenaturing
polyacrylamide (12%) gel electrophoresis. Intact dsDNA substrates were
recovered using a Qiaex II gel extraction kit (Qiagen) and stored at 4°C.
WRNp exonuclease assays were carried out in buffer containing 40 mM
Tris (pH 8.0), 4 mM MgCl2, 1 mM ATP, 0.1 mg/ml BSA, and 5 mM DTT.
Klenow exonuclease assays were carried out in 50 mM Tris (pH 7.4), 10
mM MgCl2, and 1 mM DTT; Exo III reactions were done in 67 mM Tris (pH
7.4), 0.66 mM MgCl2, and 1 mM b-mercaptoethanol. DNA substrates (3
fmoles/reaction) were incubated with Klenow (0.2–1.0 units), Exo III
(0.005–0.025 units), WRNp (45–120 fmoles), or WRNp–exo− (180 fmoles)
and, where indicated, with Ku70/Ku86 complex (12.8–1280 fmoles) for 1
hr at 37°C. The reactions (10 µl volume) were stopped by addition of an
equal volume of formamide loading buffer (80% formamide, 0.5× TBE,
0.1% xylene cyanol, and 0.1% bromophenol blue). The digestion prod-
ucts of these reactions were separated on 15% denaturing polyacrylamide
gels and visualized with a PhosphorImager (Molecular Dynamics). Quan-
titative comparison of individual lanes and generation of line graphs was
accomplished using ImageQuant software.
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